Purpose: Stem cell therapy has emerged as a promising approach for orthopaedic treatment because of their potential ability of regenerating damaged tissues. One of the challenges is the ability to track implanted cells noninvasively following implantation. Several papers have addressed the topic of visualizing and tracking transplanted cells non-invasively using superparamagnetic iron oxide (SPIO) in magnetic resonance imaging (MRI). The aim of this study is to determine if SPIO internalization interferes with the chondrogenic differentiation ability of human mesenchymal stem cells (MSCs) seeded in collagen sponge biomaterials. Methods: Human bone marrow-derived mesenchymal stem cells (hMSCs) were expanded in monolayer and are first labeled with different SPIO concentrations between 0 and 200 μg/ml Fe. The endorem-labeled hMSCs were cultured into collagen sponge during 28 days with or without TGF-β1 to induce chondrogenic differentiation. Chondrogenic gene expression (coll 2, coll 1, coll 10, aggrecan, versican, COMP, sox 9, osteocalcin, alkaline phosphatase) were investigated by using real-time quantitative RT-PCR. Synthesized extracellular matrix inside sponge was assessed histologically (proteoglycan and collagen content, SPIO detection) and immunohistochemically (coll 1, coll 2). Results: TGF-β1 induced an increase of chondrogenic gene expression (col 2, aggrecan, Sox 9, COMP) and an abundant synthesized extracellular matrix inside sponge. SPIO labeling of MSC interfered with chondrogenesis: a dose-dependent decrease of gene expression such as aggrecan, Coll 1, coll 2, Sox 9, COMP was observed in SPIO labeled cells. Histologically, the quality and the quantity of synthesized matrix were affected by SPIO labeling in a dose dependant manner. The low concentration 12.5 μg/ml Fe induced a small decrease of proteoglycan and collagen 2 content. From 50 μg/ml Fe, a marked inhibition of chondrogenesis was observed: extracellular matrix was poor in proteoglycan and collagen contents.
Purpose:
We want to analyse the impact of articular cartilage explant surfaces on chondrogenic differentiation of mesenchymal stem cells (MSCs) and properties of regenerated tissue. Furthermore, we test whether direct cell-to-cell contact between differentiated chondrocytes and undifferentiated MSCs in these experimental set ups will enhance differentiation and improve hyaline cartilage like quality and biomechanical properties of regenerated tissue. This study is designed to identify microenvironmental conditions which promote, prevent or interfere with chondrogenic differentiation of MSCs and to analyse their impact on molecular properties and quality of regenerated tissue. The aim is a better understanding of microenvironmental cues and the modulating influence of neighbouring cells and tissue interfaces on chondrogenic differentiation of chondroprogenitor cells. Methods: Articular cartilage explants and chondrocytes for our reproducible coculture regimens between chondrocytes and the chondral interface were prepared from osteoarthritic knee samples while MSCs were purchased from Lonza. MSCs/chondrocytes alone or mixed (1:1) were embedded in a fibrin-gel, providing a 3D environment and applied onto the cartilage explant surface. Cocultures were kept for up to 28 days in chondrogenic medium before being processed for analysis of gene expression (qPCR) and morphology (histology/immunohistochemistry) after 7, 14, 21 and 28 days. Chondrogenic differentiation was analyzed by staining differentiation and dedifferentiation marker as aggrecan and collagens I, II and III, supported by quantitative real-time PCR of COL1A1, COL2A1, COL3A1 and SOX9. Additionally, we quantified intracellular located collagens I and II after 28 days by using ELISAs. Viability and proliferation ability of cocultured cells was tested using a LDH-based assay and PCNA staining, respectively. Results: Vitality of chondrocytes and/or MSCs grown in a fibrin-gel applied onto an articular cartilage surface was not altered during the culture time period and a residual proliferation potential was detected in all culture conditions of our experimental setups. A chondrogenic gene expression profile was verified in MSCs and/or chondrocytes in all culture conditions. Gene expression of the dedifferentiation marker COL1A1 was decreased while the differentiation marker SOX9 and COL2A1 showed an increased gene expression in comparison to MSCs/chondrocytes in monolayer. In our coculture system with cartilage explants we have detected a reduced protein amount of collagen I and III in MSCs in comparison to MSCs grown in fibrin-gel alone. Chondrocytes cultivated together with cartilage explants produced less collagen I and II in comparison to chondrocytes grown in fibrin-gel and a mixture of chondrocytes and MSCs grown together with cartilage explants expressed less collagen I than cells grown in fibrin-gel alone.
Conclusions:
The 3D-environment of the fibrin-gel has a positive effect on the chondrogenic phenotype of chondrocytes and the chondrogenic differentiation capability of MSCs. The results of our coculture system with cartilage explants indicated an inhibition of collagens I, II and III presumably caused by cartilage -derived factors such as PtHrP, bFGF or pro-inflammatory cytokines of the Il-and TNF-family. A better understanding of this modulating influence of microenvironmental cues of cartilage on chondrogenic differentiation of MSCs could lead to a potent strategy for cell-based regeneration of either traumatic or osteoarthritic focal articular cartilage lesions. Purpose: The objective of the study is to use bioactive matrices to enhance the potency of bone morphogenetic protein 2 (BMP2), a heparan binding growth factor, and induce matrix turnover in damaged articular cartilage. Methods: Hyaluronic acid (HA) covalently bound to a domain of perlecan carrying heparan sulfate chains (HA-PlnD1) was used as a novel delivery system for controlled release of BMP2 to stimulate expression of extracellular matrix by articular cartilage cells in a mouse model of osteoarthritis (OA). OA-like damages that were induced by papain (1%) were treated seven days later by injecting intra-articularly either HA-PlnD1 preincubated with BMP2, HA-PlnD1 alone, or saline. The knees were dissected at day 7 and day 14 following these treatments and analyzed using both histological and immunohistochemical procedures. Results: Knees treated with HA-PlnD1/BMP2 had lesser damage and showed increased proteoglycan expression when compared to control knees. In addition, the HA-PlnD1/BMP2-treated knees showed enhanced detection of aggrecan by immunohistochemistry. Improvement is evident from the attenuated damage and increased matrix maintenance in treated knees versus control conditions. Ongoing work will ascertain whether this is due to increased transcript levels encoding matrix components or inhibition of degradative enzymes. Conclusions: HA-PlnD1 biomatrices thus act as an efficient in vivo delivery system for BMP2 and prolong the action of BMP2 in healing murine articular cartilage. Ultimately, HA-PlnD1/BMP2 may serve as a therapeutic agent for inducing repair of partial thickness cartilage lesions, preventing the onset of irreversible OA. (Supported by NIH COBRE P20 RR016458 to CKS).
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